Sintered dicalcium pyrophosphate increases bone mass in ovariectomized rats

Journal of Biomedical Materials Research

Volumn 59, Issue 2, 2002, Pages 246-253

  Sun, Jui Sheng ^a   Huang, Yi Chau ^b   Tsuang, Yang Hwei ^c   Chen, Li Ting ^a   Lin, Feng Huei ^a,c  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Alendronate; Bone mass; Osteoporosis; Ovariectomy; Sintered dicalcium pyrophosphate

Indexed keywords

BLOOD; BONE; CALCIUM COMPOUNDS; HISTOLOGY;

BONE MINERAL CONTENTS;

BIOLOGICAL MATERIALS;

ALENDRONIC ACID; CALCIUM PHOSPHATE DIBASIC;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MASS; BONE MINERAL; CONTROLLED STUDY; FEMALE; NONHUMAN; OVARIECTOMY; POSTMENOPAUSE OSTEOPOROSIS; RAT;

ADMINISTRATION, ORAL; ALENDRONATE; ALKALINE PHOSPHATASE; ANIMALS; BONE DENSITY; CALCIUM PYROPHOSPHATE; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; LUMBAR VERTEBRAE; OSTEOPOROSIS, POSTMENOPAUSAL; OVARIECTOMY; RATS; RATS, WISTAR;

EID: 0036132639     PISSN: 00219304     EISSN: None     Source Type: Journal    
DOI: 10.1002/jbm.1238     Document Type: Article

References (22)

1. The prevention and treatment of osteoporosis
2. Vertebral deformities as predictors of non-vertebral fractures
3. The relationship between bone density, mineral content, and mechanical strength in the femoral neck
4. Bisphosphonates: Pharmacology and use in the treatment of tumour-induced hypercalcaemic and metastatic bone disease
5. Clinical effects of bisphosphonates in involutional osteoporosis
6. 7 addition
7. The effects of calcium phosphate particles on the growth of osteoblast
8. The effect of shortterm treatment with alendronate on vertebral density and biochemical markers of bone remodeling in early postmenopausal women
9. Continuous alendronate treatment throughout growth, maturation, and aging in the rat results in increases in bone mass and mechanical properties
10. Effects of calcium phosphate bioceramics on skeletal muscle cells
11. Quantitative morphometric evaluation of the inhibitory activity of new aminobisphosphonates on bone resorption in the rat
12. Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to alendronate treatment
13. Continuous alendronate treatment throughout growth, maturation, and aging in the rat results in increases in bone mass and mechanical properties
14. The effects of 2-year treatment with the aminobisphosphonate alendronate on bone metabolism, bone histomorphometry, and bone strength in ovariectomized nonhuman primates
15. Hypercalcemia and calcium homeostasis
16. Bisphosphonate action. Alendronate localization in rat bone and effects on osteoclast ultrastructure
17. Bisphosphonates act on rat bone resorption through the mediation of osteoblasts
18. Oral alendronate induces progressive increases in bone mass of the spine, hip, and total body over 3 years in postmenopausal women with osteoporosis
19. Intermittent treatment with intravenous 4-amino-l-hydroxybutylidene-1,1-bisphosphonate (AHBuBP) in the therapy of postmenopausal osteoporosis
20. Bioceramics: Material characteristics versus in vivo behavior
21. Identification of osteoclast precursors in multi-lineage hemopoietic colonies